ACA vs DXCM · P/E 57, rev $2.88B vs P/E 63, rev $4.03B
Arcosa Inc (ACA) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the ACA and DXCM stock pages for the full models.
Not investment advice.